Condition Lookup

Gout

Specialty: Senior Health and Geriatrics

Symptoms:
sudden severe joint pain; redness; swelling; warmth; tenderness in affected joint (commonly the big toe)

Root Cause:
High levels of uric acid in the blood lead to the formation of urate crystals in joints, causing inflammation and pain.

How it's Diagnosed: videos
Joint fluid analysis to detect urate crystals, blood tests for uric acid levels, and imaging (ultrasound, X-ray, or dual-energy CT).

Treatment:
Lifestyle changes (dietary modifications, weight management), medications to manage acute attacks and prevent recurrences.

Medications:
NSAIDs like indomethacin for acute pain; colchicine to reduce inflammation; corticosteroids for severe attacks; allopurinol or febuxostat to lower uric acid levels.

Prevalence: How common the health condition is within a specific population.
Affects 4% of adults in the U.S.; more common in men and older adults.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
High purine diet, alcohol consumption, obesity, hypertension, and diuretic use.

Prognosis: The expected outcome or course of the condition over time.
Manageable with appropriate treatment and lifestyle changes; untreated gout can lead to chronic arthritis and kidney damage.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Chronic tophaceous gout, kidney stones, and joint deformities.

Phenylketonuria (PKU)

Specialty: Pediatrics

Category: Neonatal Conditions (Newborns)

Sub-category: Metabolic Disorders

Symptoms:
musty body odor; seizures; eczema; intellectual disability if untreated; delayed developmental milestones

Root Cause:
Inability to metabolize phenylalanine due to a deficiency in the enzyme phenylalanine hydroxylase.

How it's Diagnosed: videos
Newborn screening with blood test (phenylalanine levels), confirmatory genetic testing.

Treatment:
A lifelong low-phenylalanine diet, special medical formulas, and in some cases, enzyme replacement therapy.

Medications:
Sapropterin (Kuvan), a synthetic form of tetrahydrobiopterin, helps reduce phenylalanine levels in responsive patients.

Prevalence: How common the health condition is within a specific population.
Approximately 1 in 10,000 to 1 in 15,000 newborns worldwide.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Autosomal recessive inheritance; higher prevalence in certain ethnic groups.

Prognosis: The expected outcome or course of the condition over time.
Excellent with dietary management; untreated cases result in severe intellectual disability and neurological problems.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Irreversible brain damage, seizures, developmental delays, and psychological issues if untreated.

Uremia (toxins from kidney failure)

Specialty: Toxicology

Category: Endogenous Toxins

Sub-category: Metabolic Disorders

Symptoms:
nausea; vomiting; fatigue; loss of appetite; mental confusion; seizures; muscle cramps; itching; breath with a urine-like odor

Root Cause:
Accumulation of uremic toxins and waste products in the bloodstream due to impaired kidney function, leading to systemic toxicity.

How it's Diagnosed: videos
Blood tests showing elevated blood urea nitrogen (BUN) and creatinine levels; electrolyte imbalances; clinical symptoms; sometimes confirmed with imaging or biopsy of kidneys.

Treatment:
Immediate treatment often involves dialysis (hemodialysis or peritoneal dialysis) to remove toxins, along with addressing the underlying cause (e.g., managing kidney disease or acute kidney injury).

Medications:
Medications to manage symptoms and complications include antihypertensive drugs (e.g., ACE inhibitors like lisinopril or ARBs like losartan ), phosphate binders (e.g., sevelamer ), erythropoiesis-stimulating agents (e.g., epoetin alfa) to manage anemia, and diuretics (e.g., furosemide ) to reduce fluid overload.

Prevalence: How common the health condition is within a specific population.
Common among patients with chronic kidney disease (CKD), especially in end-stage renal disease (ESRD). Affects approximately 15% of the global population with CKD.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Chronic kidney disease, diabetes, hypertension, recurrent urinary tract infections, genetic predisposition, nephrotoxic medications.

Prognosis: The expected outcome or course of the condition over time.
Treatable with dialysis or kidney transplant; prognosis depends on the underlying cause and overall health of the patient. Without treatment, it can be fatal.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Heart disease, fluid overload, pericarditis, electrolyte imbalances (e.g., hyperkalemia), neuropathy, bone disease.